- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Daewon Pharm (003220)
Track today's live Daewon Pharm (003220) share price, performance and key data on this page with our current Seoul:003220 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Daewon Pharm share price on the Seoul exchange. Use the dropdown to switch exchange for the 003220 share price, head to our technical summary section, which provides analysis on Daewon Pharm share price buy/sell indicators using real-time data (or discuss the Daewon Pharm (003220) stock price today with other investors in the Daewon Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS:003220 share price (ISIN: KR7003220001) to enhance your trading decisions with our free investment tools and resources.
What Is the Daewon Pharm Share Price Today?
The Daewon Pharm share price today is 8,290.
What Is the Stock Symbol for Daewon Pharm
The stock symbol (or 'ticker') for Daewon Pharm is "003220."
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul stock exchange.
Is Daewon Pharm a Good Stock to Buy?
Determining whether Daewon Pharm (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KS:003220 share price (ISIN: KR7003220001) to enhance your trading decisions with our free investment tools and resources.
What Is the Daewon Pharm Share Price Today?
The Daewon Pharm share price today is 8,290.
What Is the Stock Symbol for Daewon Pharm
The stock symbol (or 'ticker') for Daewon Pharm is "003220."
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul stock exchange.
Is Daewon Pharm a Good Stock to Buy?
Determining whether Daewon Pharm (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Seoul
Currency in KRW
8,290
-250(-2.93%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,170
8,640
52 wk Range
8,070
13,700
003220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,1708,640
52 wk Range
8,07013,700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.02%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.02%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
003220 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
14,667
Upside
+76.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14,667
(+76.92% Upside)
Earnings
Latest Release
15/05/2026
EPS / Forecast
117.00 / 140.70
Revenue / Forecast
158.1B / 169.9B
Compare 003220 to Peers and Sector
Metrics to compare | 003220 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003220PeersSector | |
|---|---|---|---|---|
P/E Ratio | −73.4x | 7.5x | −0.4x | |
PEG Ratio | 0.52 | 0.08 | 0.00 | |
Price/Book | 0.7x | 0.7x | 2.6x | |
Price / LTM Sales | 0.3x | 0.5x | 3.0x | |
Upside (Analyst Target) | 75.6% | 75.4% | 58.1% | |
Fair Value Upside | Unlock | 25.3% | 8.2% | Unlock |
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Daewon Pharm (Seoul: 003220) Share Price Today?
The Daewon Pharm stock price today is 8,290 KRW.
What Stock Exchange Does Daewon Pharm (003220) Trade On?
Daewon Pharm is listed and trades on the Seoul Stock Exchange.
What Is the Ticker (Stock Symbol) for Daewon Pharm?
The stock symbol (also called a 'ticker') for Daewon Pharm is "003220."
Does Daewon Pharm Pay Dividends? What’s The Current 003220 Dividend Yield?
Yes, 003220 Pays Dividends to its Shareholders. The current Daewon Pharm dividend yield is 3.02%.
What Is the Current Daewon Pharm Market Capitalisation?
As of today, Daewon Pharm (Seoul: 003220) market cap is 177.68B KRW.
What Is Daewon Pharm's (003220) Earnings Per Share (TTM)?
The Daewon Pharm EPS is currently -134 (Trailing Twelve Months).
When Is the Next Daewon Pharm Earnings Date?
Daewon Pharm's next earnings report will be released on 18/08/2026.
Is 003220 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Daewon Pharm moving averages and other technical indicators, the daily buy/sell signal for 003220 stock is Strong Sell.
How Many Times Has Daewon Pharm Stock Split?
Daewon Pharm has split 17 times. (See the 003220 stock split history page for full effective split date and price information.)
How Many Employees Does Daewon Pharm Have?
Daewon Pharm has 1283 employees, based on their latest Companies House report.
What is the current trading status of Daewon Pharm (Seoul: 003220)?
As of 22/06/2026, Daewon Pharm (003220) is trading at a share price of 8,290 KRW, with a previous close of 8,540 KRW. The stock has fluctuated within a day range of 8,170 KRW to 8,640 KRW, while its 52-week range spans from 8,070 KRW to 13,700 KRW.
What Is Daewon Pharm (003220) Price Target According to Analysts?
The average 12-month price target for Daewon Pharm is 14,667 KRW, with a high estimate of 16000 KRW and a low estimate of 13000 KRW. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +76.92% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.